Efficacy and safety of mepolizumab administered subcutaneously for moderate to severe atopic dermatitis
Kang, Eunhye G., Narayana, Poornima Krishnamurthy, Pouliquen, Isabelle J., Lopez, Monica C., Ferreira‐Cornwell, M. Celeste, Getsy, John A.
Published in Allergy (Copenhagen) (01.04.2020)
Published in Allergy (Copenhagen) (01.04.2020)
Get full text
Journal Article
Subcutaneous ofatumumab in patients with relapsing-remitting multiple sclerosis: The MIRROR study
Bar-Or, Amit, Grove, Richard A, Austin, Daren J, Tolson, Jerry M, VanMeter, Susan A, Lewis, Eric W, Derosier, Frederick J, Lopez, Monica C, Kavanagh, Sarah T, Miller, Aaron E, Sorensen, Per S
Published in Neurology (15.05.2018)
Published in Neurology (15.05.2018)
Get more information
Journal Article
Author response: Subcutaneous ofatumumab in patients with relapsing-remitting multiple sclerosis: The MIRROR study
Bar-Or, Amit, Grove, Richard A, Tolson, Jerry M, Derosier, Frederick J, Lopez, Monica C, Kavanagh, Sarah T, Miller, Aaron E
Published in Neurology (12.03.2019)
Published in Neurology (12.03.2019)
Get more information
Journal Article